ARCHIVES

NCAB Defends Organ Site Program, But DeVita Still Plan to Discuss It With Cancer Panel

This article is from The Cancer Letter archive.

Vol. 06 No. 41 | October 17, 1980

Download PDF Visit The Full Archive

Related Articles

Study Finds Gene Expression Test Predicts Stage I or II Recurrence

August 30, 2013

In Brief: Lichter, Bailes Lead ASCO; NCI Names Vande Woude Basic Sciences Director

May 22, 1998

Who Will Determine Pay Lines For Each Program at NCI? Upton Suggests A Collective Approach

February 17, 1978

DeLap: Seven Years In industry Provided View Of Pressures On Drug Developers

August 2, 1996

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Authorization Bill Passes Senate 82-0

June 27, 1980